Skip to main content

Table 2 Clinical markers of the study participants at baseline (M0), JUSH, Southwest Ethiopia, 2007.

From: Predictors of adherence to antiretroviral therapy among HIV-infected persons: a prospective study in Southwest Ethiopia

Characteristics Fr (%)
WHO disease stage when HAART started (N = 400)  
   I 3(.8)
   II 33(8.3)
   III 265(66.3)
   IV 99(24.8)
CD4 count when the treatment was started (N = 374)  
   ≥ 500 3(.8)
   200–499 101(27.0)
   < 200 270(72.2)
Duration of treatment in months (N = 400)  
   3–12 279(69.8)
   13–24 112(28.0)
   ≥ 25 9(2.3)
Clinical Follow Up (N = 400)  
   Monthly 384(96.0)
   Every two month 15(3.8)
   Every three month 1(.3)